NCT01646567View on ClinicalTrials.gov

SHP-141C in Plaque Type Psoriasis

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Plaque Type Psoriasis
Interventions
DRUG

SHP-141C

Topical Cream

DRUG

Placebo to SHP-141C

Placebo Topical Cream

DRUG

Betamethasone Valerate

Topical cream, 0.02%

DRUG

Calcipotriol

Topical cream, 0.005%

Trial Locations (1)

3004

Nucleus Network Limited, Melbourne

Sponsors
All Listed Sponsors
lead

TetraLogic Pharmaceuticals

INDUSTRY

NCT01646567 - SHP-141C in Plaque Type Psoriasis | Biotech Hunter | Biotech Hunter